scholarly article | Q13442814 |
P819 | ADS bibcode | 2018NatCo...9.4239A |
P356 | DOI | 10.1038/S41467-018-06208-Y |
P932 | PMC publication ID | 6185954 |
P698 | PubMed publication ID | 30315161 |
P50 | author | Yi Zhang | Q57480296 |
Edward Ayoub | Q58517942 | ||
Archibald S Perkins | Q58670822 | ||
Kathleen E McGrath | Q92246497 | ||
Laura M. Calvi | Q42723493 | ||
P2093 | author name string | Michael P Wilson | |
James Palis | |||
Benjamin J Frisch | |||
Allison J Li | |||
P2860 | cites work | Pbx1 is a downstream target of Evi-1 in hematopoietic stem/progenitors and leukemic cells | Q24317653 |
Musashi-2 regulates normal hematopoiesis and promotes aggressive myeloid leukemia | Q24597256 | ||
Negative cross-talk between hematopoietic regulators: GATA proteins repress PU.1 | Q24671782 | ||
Infection-induced changes in hematopoiesis | Q27027365 | ||
High EVI1 expression predicts poor survival in acute myeloid leukemia: a study of 319 de novo AML patients | Q28209409 | ||
Identification of binding sites of EVI1 in mammalian cells | Q28260755 | ||
The MDS1-EVI1 gene complex as a retrovirus integration site: impact on behavior of hematopoietic cells and implications for gene therapy | Q28266315 | ||
The LMO2 oncogene regulates DNA replication in hematopoietic cells | Q28272026 | ||
Retroviral activation of a novel gene encoding a zinc finger protein in IL-3-dependent myeloid leukemia cell lines | Q28281211 | ||
Impairment of natural killer cytotoxic activity and interferon gamma production in CCAAT/enhancer binding protein gamma-deficient mice | Q28510979 | ||
Mutation at the Evi1 locus in Junbo mice causes susceptibility to otitis media | Q28586559 | ||
PR-domain-containing Mds1-Evi1 is critical for long-term hematopoietic stem cell function | Q33395759 | ||
Both AML1 and EVI1 oncogenic components are required for the cooperation of AML1/MDS1/EVI1 with BCR/ABL in the induction of acute myelogenous leukemia in mice | Q42832388 | ||
Analysis of hematopoietic progenitors in the mouse embryo | Q45113266 | ||
Evi1 represses PTEN expression and activates PI3K/AKT/mTOR via interactions with polycomb proteins. | Q45345900 | ||
Identification of regulatory networks in HSCs and their immediate progeny via integrated proteome, transcriptome, and DNA methylome analysis. | Q46456469 | ||
Reciprocal activation of GATA-1 and PU.1 marks initial specification of hematopoietic stem cells into myeloerythroid and myelolymphoid lineages | Q46678691 | ||
Efficient method to generate single-copy transgenic mice by site-specific integration in embryonic stem cells | Q46885318 | ||
Acute myeloid leukemia induced by graded reduction of a lineage-specific transcription factor, PU.1. | Q47597394 | ||
3q26.2/EVI1 rearrangement is associated with poor prognosis in classical Philadelphia chromosome-negative myeloproliferative neoplasms. | Q50776559 | ||
Chromosomal abnormality inv(3)(q21q26) associated with multilineage hematopoietic progenitor cells in hematopoietic malignancies | Q51102350 | ||
Cooperative and antagonistic interplay between PU.1 and GATA-2 in the specification of myeloid cell fates. | Q52112384 | ||
High EVI1 levels predict adverse outcome in acute myeloid leukemia: prevalence of EVI1 overexpression and chromosome 3q26 abnormalities underestimated. | Q54546717 | ||
Regulation of the PU.1 gene by distal elements | Q57615588 | ||
Patterns of Evi-1 expression in embryonic and adult tissues suggest that Evi-1 plays an important regulatory role in mouse development | Q67975653 | ||
Common sites of viral integration in lymphomas arising in AKXD recombinant inbred mouse strains | Q68846816 | ||
The carboxyl domain of zinc fingers of the Evi-1 myeloid transforming gene binds a consensus sequence of GAAGATGAG | Q72420809 | ||
Identification of a breakpoint cluster region 3' of the ribophorin I gene at 3q21 associated with the transcriptional activation of the EVI1 gene in acute myelogenous leukemias with inv(3)(q21q26) | Q72699060 | ||
Erythroid defects and increased retrovirally-induced tumor formation in Evi1 transgenic mice | Q73166088 | ||
New insights into the prognostic impact of the karyotype in MDS and correlation with subtypes: evidence from a core dataset of 2124 patients | Q80860421 | ||
Myelodysplastic syndrome with inv(3)(q21q26.2) or t(3;3)(q21;q26.2) has a high risk for progression to acute myeloid leukemia | Q84561568 | ||
NUP98/11p15 translocations affect CD34+ cells in myeloid and T lymphoid leukemias | Q85201352 | ||
Rearrangements of chromosome 3 involving bands 3q21 and 3q26 are associated with normal or elevated platelet counts in acute nonlymphocytic leukemia | Q93644788 | ||
Distinct, strict requirements for Gfi-1b in adult bone marrow red cell and platelet generation | Q33569847 | ||
Flexible Accelerated STOP Tetracycline Operator-knockin (FAST): a versatile and efficient new gene modulating system | Q34263796 | ||
Abnormalities of 3q21 and 3q26 in myeloid malignancy: a United Kingdom Cancer Cytogenetic Group study | Q34369958 | ||
Recombineering: a powerful new tool for mouse functional genomics | Q34389493 | ||
A single oncogenic enhancer rearrangement causes concomitant EVI1 and GATA2 deregulation in leukemia | Q34413730 | ||
Ectopic expression of Oct-4 blocks progenitor-cell differentiation and causes dysplasia in epithelial tissues | Q34417194 | ||
Transcriptome-wide noise controls lineage choice in mammalian progenitor cells | Q34780848 | ||
Global Identification of EVI1 Target Genes in Acute Myeloid Leukemia | Q34796524 | ||
Inflammation and the reciprocal production of granulocytes and lymphocytes in bone marrow | Q35951254 | ||
The T cell leukemia LIM protein Lmo2 is necessary for adult mouse hematopoiesis. | Q36011931 | ||
EVI1 acts as an inducible negative-feedback regulator of NF-κB by inhibiting p65 acetylation | Q36016473 | ||
Cutting Edge: Hematopoietic Stem Cell Expansion and Common Lymphoid Progenitor Depletion Require Hematopoietic-Derived, Cell-Autonomous TLR4 in a Model of Chronic Endotoxin. | Q36031575 | ||
Clinical and prognostic significance of 3q26.2 and other chromosome 3 abnormalities in CML in the era of tyrosine kinase inhibitors | Q36219652 | ||
Immunization and infection change the number of recombination activating gene (RAG)-expressing B cells in the periphery by altering immature lymphocyte production | Q36368599 | ||
Dynamic regulation of PU.1 expression in multipotent hematopoietic progenitors | Q36402594 | ||
Targeting of the bone marrow microenvironment improves outcome in a murine model of myelodysplastic syndrome | Q36547805 | ||
Evi-1, a murine zinc finger proto-oncogene, encodes a sequence-specific DNA-binding protein | Q36692472 | ||
Impaired granulopoiesis, myelodysplasia, and early lethality in CCAAT/enhancer binding protein epsilon-deficient mice. | Q36721547 | ||
Targeting a DNA binding motif of the EVI1 protein by a pyrrole-imidazole polyamide | Q36749396 | ||
Toll-like receptor 4/stem cell antigen 1 signaling promotes hematopoietic precursor cell commitment to granulocyte development during the granulopoietic response to Escherichia coli bacteremia. | Q36911380 | ||
EVI1 Interferes with Myeloid Maturation via Transcriptional Repression of Cebpa, via Binding to Two Far Downstream Regulatory Elements | Q37034398 | ||
Alcohol impairs the myeloid proliferative response to bacteremia in mice by inhibiting the stem cell antigen-1/ERK pathway. | Q37195600 | ||
Essential role of PR-domain protein MDS1-EVI1 in MLL-AF9 leukemia | Q37235697 | ||
The anemia of inflammation | Q38065016 | ||
The role of EVI1 in myeloid malignancies | Q38185179 | ||
Emergency granulopoiesis | Q38206076 | ||
A remote GATA2 hematopoietic enhancer drives leukemogenesis in inv(3)(q21;q26) by activating EVI1 expression | Q39313400 | ||
Inferring rules of lineage commitment in haematopoiesis | Q39394890 | ||
EVI1 Impairs myelopoiesis by deregulation of PU.1 function | Q39885071 | ||
EVI1 induces myelodysplastic syndrome in mice | Q39951095 | ||
Regulation of CCAAT/enhancer-binding protein (C/EBP) activator proteins by heterodimerization with C/EBPgamma (Ig/EBP). | Q40735316 | ||
PU.1 inhibits GATA-1 function and erythroid differentiation by blocking GATA-1 DNA binding | Q40850691 | ||
Lymphohematopoietic progenitors immortalized by a retroviral vector harboring a dominant-negative retinoic acid receptor can recapitulate lymphoid, myeloid, and erythroid development | Q41414243 | ||
Distinctive and indispensable roles of PU.1 in maintenance of hematopoietic stem cells and their differentiation. | Q42194328 | ||
Ubiquitous and uniform in vivo fluorescence in ROSA26-EGFP BAC transgenic mice | Q42773641 | ||
P433 | issue | 1 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | general chemistry | Q909510 |
hemopoiesis | Q919283 | ||
overexpression | Q61643320 | ||
P304 | page(s) | 4239 | |
P577 | publication date | 2018-10-12 | |
P1433 | published in | Nature Communications | Q573880 |
P1476 | title | EVI1 overexpression reprograms hematopoiesis via upregulation of Spi1 transcription | |
P478 | volume | 9 |